In this work, we identified that the LINC01004-SPI1 axis leads to SIGLEC9 activation, which engages MUC1 to trigger the formation of immunosuppressive TME and radioresistance in ESCC. Here, SIGLEC9 is linked to esophageal squamous cell carcinoma.